NYSEARCA:GPGCX Grandeur Peak Global Contrarian Instl (GPGCX) Price, Holdings, & News → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free GPGCX Stock Alerts $15.17 -0.01 (-0.07%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$15.17▼$15.1750-Day Range$14.51▼$15.4752-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AAssets Under Management$5.93 millionDividend YieldN/ANet Expense Ratio0.00% Stock AnalysisStock AnalysisChartStock AnalysisChart Get Grandeur Peak Global Contrarian Instl alerts: Email Address About Grandeur Peak Global Contrarian InstlRead More GPGCX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GPGCX ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive GPGCX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Grandeur Peak Global Contrarian Instl and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details Issuer Fund NameGrandeur Peak Global Contrarian - Institutional Tax Classification Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:GPGCX Inception Date1/1/2100 Fund ManagerN/A WebN/A PhoneN/AFund Focus Asset Class BenchmarkN/A Category Focus Development Level Region Number of Holdings0 Fund Statistics Assets Under Management$5.93 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorN/A AdvisorN/A CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding SharesN/ABetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. Grandeur Peak Global Contrarian Instl ExpensesTypeGPGCXNYSEARCA ETFsAll ETFsManagement Fee0.00%0.50%0.51%Other Expenses0.00%0.64%0.58%Total Expense0.00%0.74%0.70%Fee Waiver0.00%-0.68%-0.57%Net Expense0.00%0.58%0.58% Grandeur Peak Global Contrarian Instl (GPGCX)Full Holdings Details Similar ETFsXtrackers MSCI All China Equity ETFNYSEARCA:CNishares Paris-Aligned Climate MSCI World Ex USA ETFNYSEARCA:PABDInnovator Double Stacker 9 Buffer ETF - JanuaryNYSEARCA:DBJAGlobal Beta Low Beta ETFNYSEARCA:GBLOInvesco US Large Cap Core ESG ETFNYSEARCA:IVLC GPGCX ETF - Frequently Asked Questions How have GPGCX shares performed in 2024? Grandeur Peak Global Contrarian Instl's stock was trading at $15.00 at the beginning of the year. Since then, GPGCX stock has increased by 1.1% and is now trading at $15.17. View the best growth stocks for 2024 here. How do I buy shares of Grandeur Peak Global Contrarian Instl? Shares of GPGCX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:GPGCX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJim Cramer’s “The Biggest Drug Ever”Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grandeur Peak Global Contrarian Instl Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.